Heron Therapeutics is trading at $0.29, up 5.21%, alongside biotech-sector strength.
- No verified company-specific announcement explaining the November 6 move surfaced; third-quarter results are scheduled for November 9.
- XBI was up 2.01%. Moderna’s earnings beat and raised 2026 revenue outlook provided positive industry context, but do not establish a direct Heron-specific catalyst.
- Trading is live in the regular session; volume details are unavailable in the supplied price context.